Arvinas And Macroceutics Establish DEL Screening Collaboration On Undruggable Targets
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, and Macroceutics, Inc., today announced the establishment of...
SQI Signs Agreement With A World-Leading Pharmaceutical Company
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced it...
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda in Europe
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter “Sumitomo Dainippon Pharma”) and Angelini S.p.A. announced that the companies have...
Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases
Boehringer Ingelheim and MiNA Therapeutics (“MiNA”), a pioneer in RNA activation therapeutics, announced that they have signed a collaboration and licensing agreement focused on...
Adaptive Biotechnologies Announces a Collaboration with Amgen to Advance Clinical Development of the clonoSEQ Assay in Multiple Myeloma
Adaptive Biotechnologies, a leader in combining next-generation sequencing (NGS) and sophisticated bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces...
Dermira and UCB Agree to End Collaboration Agreement for CIMZIA
Dermira, Inc and UCB announced the companies have agreed to end their development and commercialization agreement for CIMZIA (certolizumab pegol) in psoriasis. Following positive...
PCI Announces Further Investment in Fully Contained Xcelodose® 600S Technology Delivering Excellence in Clinical Services
PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at our center of excellence for contained...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...